Business Daily
Weight-loss drugs. Who pays?
Mar 02, 2026
· 17m
<p>GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.</p><p>Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — are now widely prescribed for weight loss, with growing evidence they can also reduce the risk of heart disease and stroke.</p><p>But in the United States, access to GLP-1 drugs often depends on insurance coverage — and on who can afford to pay.</p><p>In this …
अस्मिन् प्रकरणे अद्यापि हस्तलिखितं नास्ति
STT.ai येन इदं प्रकरणं कृत्रिमबुद्धिद्वारा लिखितं भवति । वक्तृत्वबोधेन, समयसूचनानि, तथा बहुविधेषु फॉर्मेटेषु निर्यातेन च सटीकः पाठः प्राप्तः भवति ।
वक्तृ- पत्ता
शब्द-स्तरीय-समय-चिह्नानि
निर्यातं SRT, TXT, JSON रूपेण